Abstract

Publisher Summary This chapter describes an experiment in which splenic lymphocytes of mice, immunized with membrane-enriched fractions of human metastatic mammary carcinoma cells, were fused with murine non- immunog1obulin secretor myeloma cells. Following initial screening and double cloning of hybridoma cultures, 11 monoclonal antibodies were further characterized. These monoclonals could be placed into five major groups based on their differential reactivities with extracts of breast tumor metastases, the surface of live mammary tumor cells in culture, and immunoper-oxidase staining of tissue sections of primary and metastatic mammary tumors. None of the antibodies bound to the surface of 14 human cell lines were derived from a variety of normal tissues, including normal mammary cells. Surface binding to mammary tumor cells by two of the monoclonal antibodies was shown to decrease during density dependent arrest, and further cell-cycle analysis demonstrated differential antibody surface binding at S phase. Prolonged exposure of mammary tumor cells to antibody showed no evidence of antigen capping or internalization.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.